Your browser doesn't support javascript.
loading
Case Report: Ischemic Colitis in Severe COVID-19 Pneumonia: An Unforeseen Gastrointestinal Complication.
Paul, Theresa; Joy, Antony Raphel; Alsoub, Hussam Abdel Rahman S; Parambil, Jessiya Veliyankodan.
Afiliação
  • Paul T; 1Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Joy AR; 2Department of Gastroenterology, Hamad Medical Corporation, Doha, Qatar.
  • Alsoub HARS; 3Department of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar.
  • Parambil JV; 1Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Am J Trop Med Hyg ; 104(1): 63-65, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33146121
Clinical manifestations and complications of SARS-CoV-2 are still emerging and variant. Gastrointestinal (GI) manifestations and complications are hugely under-recognized. The presence of angiotensin converting enzyme-2 receptors in the intestinal enterocytes, the receptors primarily involved in the pathogenesis of COVID-19 pneumonia, maybe the key factor contributing to the pathogenesis of GI manifestations. Ischemic colitis, although the most common ischemic pathology of the GI tract, is relatively rare, occurring as a result of colonic hypoperfusion. The innumerable causes of colonic ischemia are categorized into occlusive and nonocclusive pathologies. Here, we have discussed a case of severe COVID-19 pneumonia, developing ischemic colitis, as a rare GI complication. The cause of ischemia in COVID-19 pneumonia is multifactorial, including hypercoagulable state, coagulopathy leading to thromboembolic complications, and use of vasopressors in severely ill patients with hemodynamic compromise.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Isquêmica / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Isquêmica / SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article